Aclasta/Zoledronate


Indications and Reactions:

Role Indications Reactions
Primary
Osteoporosis 59.2%
Rheumatoid Arthritis 6.1%
Osteoporotic Fracture 4.5%
Hypertension 3.9%
Osteoporosis Postmenopausal 2.8%
Asthma 2.2%
Depression 2.2%
Hypercholesterolaemia 2.2%
Osteonecrosis 2.2%
Pain 2.2%
Organ Transplant 1.7%
Ulcer 1.7%
Breast Cancer 1.1%
Constipation 1.1%
Dyspepsia 1.1%
Eye Infection 1.1%
Hypovitaminosis 1.1%
Mineral Supplementation 1.1%
Osteopenia 1.1%
Osteoporosis Prophylaxis 1.1%
Rib Fracture 10.7%
Death 8.9%
Spinal Fracture 8.9%
Fall 7.1%
Wrist Fracture 7.1%
Hip Fracture 5.4%
Loss Of Consciousness 5.4%
Pain 5.4%
Syncope 5.4%
Heart Rate Abnormal 3.6%
Humerus Fracture 3.6%
Pubis Fracture 3.6%
Renal Failure Chronic 3.6%
Sciatica 3.6%
Skeletal Injury 3.6%
Thoracic Vertebral Fracture 3.6%
Upper Limb Fracture 3.6%
Vomiting 3.6%
Adenocarcinoma Pancreas 1.8%
Bladder Prolapse 1.8%
Secondary
Osteoporosis 64.5%
Rheumatoid Arthritis 5.6%
Dyspepsia 4.0%
Constipation 3.2%
Hypertension 3.2%
Osteoporosis Postmenopausal 3.2%
Osteoporotic Fracture 3.2%
Hypercholesterolaemia 2.4%
Sleep Disorder 2.4%
Migraine 1.6%
Pain 1.6%
Asthma 0.8%
Chondrocalcinosis 0.8%
Gastrooesophageal Reflux Disease 0.8%
Prophylaxis 0.8%
Temporal Arteritis 0.8%
Type 2 Diabetes Mellitus 0.8%
Spinal Fracture 8.6%
Ilium Fracture 6.9%
Pubis Fracture 6.9%
Radius Fracture 6.9%
Renal Failure Chronic 6.9%
Wrist Fracture 6.9%
Hip Fracture 5.2%
Oesophageal Carcinoma 5.2%
Rib Fracture 5.2%
Sense Of Oppression 5.2%
Syncope 5.2%
Cardiac Failure 3.4%
Cerebrovascular Accident 3.4%
Fall 3.4%
Heart Rate Abnormal 3.4%
Impaired Healing 3.4%
Lung Neoplasm Malignant 3.4%
Pancreatic Carcinoma 3.4%
Pelvic Adhesions 3.4%
Single Functional Kidney 3.4%

Drug Data